ATB-1606

N/A

Report date: 2024/07/05 10:51:55
NME

Base Information

Drug NameATB-1606
Drug Alias NameATB-1606
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThymic stromal lymphopoietin modulators
TargetsThymic stromal lymphopoietin
Therapy Area/IndicationsDermatitis, AtopicInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAmtixBio Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAmtixBio Co Ltd
Inactive CompaniesN/A
Active IndicationsDermatitis, AtopicInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A